Group 1 - The stock price of Har Sanlian is reported at 14.44 yuan as of August 27, 2025, down 3.80% from the previous trading day [1] - The company achieved a revenue of 413 million yuan in the first half of 2025, a year-on-year decline of 21.08%, with a net profit loss of 92.39 million yuan, reversing from profit to loss [1] - The pharmaceutical segment's revenue decreased by 24.25%, significantly impacting overall performance, while new ventures in animal health and wellness are still in the investment phase and have not yet contributed to profitability [1] Group 2 - On August 27, 2025, Har Sanlian experienced a net outflow of 38.09 million yuan in principal funds, with a cumulative net outflow of 90.42 million yuan over the past five days [2]
哈三联股价下跌3.80% 上半年净亏损超九千万